S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Opko HealthGossamer BioKaryopharm TherapeuticsMyovant SciencesAchillion Pharmaceuticals
SymbolNASDAQ:OPKNASDAQ:GOSSNASDAQ:KPTINYSE:MYOVNASDAQ:ACHN
Price Information
Current Price$1.16$10.03$17.80$7.76$6.76
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$3.17$27.80$30.71$23.75$4.40
% Upside from Price Target174.17% upside177.17% upside72.55% upside206.06% upside-34.91% downside
Trade Information
Market Cap$810.49 million$665.39 million$1.18 billion$659.04 million$946.72 million
Beta1.740.671.692.21.59
Average Volume32,135,324494,3841,818,1441,025,8228,439,141
Sales & Book Value
Annual Revenue$901.90 millionN/A$40.89 millionN/AN/A
Price / Sales0.86N/A28.53N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.43 per share$5.34 per share$0.79 per share$0.06 per share$1.92 per share
Price / Book0.48N/A22.53N/AN/A
Profitability
Net Income$-314,920,000.00$-180,310,000.00$-199,590,000.00$-273,550,000.00$-70,270,000.00
EPS($0.41)($3.29)($3.22)($4.09)($0.51)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-34.92%N/A-488.08%N/AN/A
Return on Equity (ROE)-14.41%-43.11%-254.74%-2,288.94%-30.95%
Return on Assets (ROA)-9.99%-37.57%-71.41%-162.25%-29.09%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.15%0.11%2.47%5.88%0.01%
Current Ratio1.30%11.09%6.01%2.08%8.96%
Quick Ratio1.09%11.09%6.00%2.08%8.96%
Ownership Information
Institutional Ownership Percentage26.28%61.21%89.95%36.87%79.42%
Insider Ownership Percentage42.25%23.30%13.26%3.68%4.58%
Miscellaneous
Employees6,0961183328656
Shares Outstanding669.83 million66.34 million65.55 million89.79 million140.05 million
Next Earnings Date5/5/2020 (Estimated)5/12/2020 (Estimated)5/14/2020 (Estimated)5/22/2020 (Estimated)5/7/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel